CAS 301326-22-7

Formel: C19H19N5O

InChl: InChI=1S/C19H19N5O/c1-13-6-4-5-7-17(13)23-22-15-8-9-16(14(2)12-15)21-19(25)18-10-11-20-24(18)3/h4-12H,1-3H3,(H,21,25)

InChI Key: LKTNEXPODAWWFM-UHFFFAOYSA-N

SMILES: CC1=CC=CC=C1N=NC2=CC(=C(C=C2)NC(=O)C3=CC=NN3C)C

CH-223191

CAS: 301326-22-7

Formel: C₁₉H₁₉N₅O

Reinheit: >97.0%(HPLC)(qNMR)

Farbe und Form: White to Light yellow to Light orange powder to crystal

Molekulargewicht: 333.40

Ref: 3B-C4042

1-Methyl-N-(2-methyl-4-(o-tolyldiazenyl)phenyl)-1H-pyrazole-5-carboxamide

CAS: 301326-22-7

Formel: C₁₉H₁₉N₅O

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 333.3871

Ref: IN-DA00BEB7

CH-223191

CAS: 301326-22-7

Formel: C₁₉H₁₉N₅O

Reinheit: ≥ 98.0%

Farbe und Form: White to yellow or orange powder to crystals

Molekulargewicht: 333.39

Ref: 7W-GL9879

CH-223191

CAS: 301326-22-7

CH-223191

Formel: C₁₉H₁₉N₅O

Reinheit: ≥98%

Molekulargewicht: 333.39

Ref: 54-BUP13402

1-Methyl-N-(2-Methyl-4-(o-Tolyldiazenyl)Phenyl)-1H-Pyrazole-5-Carboxamide

CAS: 301326-22-7

1-Methyl-N-(2-Methyl-4-(o-Tolyldiazenyl)Phenyl)-1H-Pyrazole-5-Carboxamide

Formel: C₁₉H₁₉N₅O

Reinheit: ≥98%

Molekulargewicht: 333.39

Ref: 54-OR1009541

CH 223191

Kontrolliertes Produkt

CAS: 301326-22-7

Applications CH 223191 is a novel antagonist of the aryl hydrocarbon receptor.
References Choi, E., et. al.: Mol. Pharmacol., 81, 3 (2012)

Formel: C₁₉H₁₉N₅O

Farbe und Form: Neat

Molekulargewicht: 333.39

Ref: TR-C291805

CH-223191

CAS: 301326-22-7

1-Methyl-N-(2-methyl-4-(o-tolyldiazenyl)phenyl)-1H-pyrazole-5-carboxamide

Formel: C₁₉H₁₉N₅O

Reinheit: 98%

Molekulargewicht: 333.39

Ref: IN-DG303974

CH-223191

CAS: 301326-22-7

CH-223191, a specific aryl hydrocarbon receptor (AhR) antagonist, inhibited TCDD-induced luciferase activity with an IC50 of 0.03 μM. High-Quality, Low-Cost!

Formel: C₁₉H₁₉N₅O

Reinheit: 99.01% - 99.87%

Farbe und Form: Orange Solid

Molekulargewicht: 333.3871

Ref: TM-T2448

CH-223191

CAS: 301326-22-7

CH-223191 is a potent and selective DNA polymerase chain reaction (PCR) antagonist that prevents the synthesis of double-stranded DNA. It binds to the aryl hydrocarbon receptor (AHR), which is involved in mediating toxic effects of certain environmental pollutants. CH-223191 has been shown to be an AHR antagonist, preventing activation of proinflammatory cytokines such as IL-6 and IL-8 in human hepg2 cells. This agent also inhibits the expression of proinflammatory genes, including MMP-9, COX-2, and TNF-α. Additional studies have shown that CH-223191 has lead optimization potential for anticancer drugs due to its ability to inhibit proliferation and induce apoptosis in cancer cells at low levels.

Formel: C₁₉H₁₉N₅O

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 333.40 g/mol

Ref: 3D-FC137662